Govt Rejects SII Plea To Export 50 Lakh Doses Of Covishield To UK

NEW DELHI : Despite the international pressure and several rounds of negotiations by Serum Institute of India (SII), the government has turned down the request from SII to export 50 lakh doses of Covishield to UK under its prior commitments.

The decision was taken in the wake of severe supply crunch of vaccines locally and government insisting the local production be supplied to protect Indians first.

States have been prompted to approach the Pune-based company to negotiate contracts to procure these doses to meet local demand. The doses are likely to be used to vaccinate those between 18-44 age.

“These 50 lakh doses of Covishield vaccine are now available for inoculating people between 18-44 years age. States have been asked to procure it. Private hospitals can also get them,” an official source said.

The ministry has asked the states to contact the company and initiate procurement activity at the earliest. However, sources said, the labels of these doses may have to be changed. Since the vaccines were packed for supply to the UK, a different label was affixed on the vials but now since they have to be supplied in the local market, they need a label for the same.

  • Related Posts

    • Pharma
    • July 15, 2025
    • 100 views
    Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

    Sun Pharmaceutical Industries Ltd has announced that it has entered into a settlement and license agreement with Incyte Corporation regarding litigation related to LEQSELVI (deuruxolitinib). “Under the terms of agreement,…

    • Pharma
    • July 15, 2025
    • 114 views
    Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

    Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of the generic…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

    Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

    Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

    Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

    Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

    Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients

    Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

    Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR